AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis
Dae Gyu Kim(Yonsei University), Sung‐Hoon Kim(Seoul National University)
Cited by 11
Related Papers
Control of leucine-dependent mTORC1 pathway through chemical intervention of leucyl-tRNA synthetase and RagD interaction
|Nature Communications|2017|99
Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug
|BMC Systems Biology|2012|94
Caspase-8 controls the secretion of inflammatory lysyl-tRNA synthetase in exosomes from cancer cells
|The Journal of Cell Biology|2017|89
Anethole Exerts Antimetatstaic Activity via Inhibition of Matrix Metalloproteinase 2/9 and AKT/Mitogen-Activated Kinase/Nuclear Factor Kappa B Signaling Pathways
|Biological and Pharmaceutical Bulletin|2011|86